1. Home
  2. XELB vs QNRX Comparison

XELB vs QNRX Comparison

Compare XELB & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XELB
  • QNRX
  • Stock Information
  • Founded
  • XELB 2011
  • QNRX 2018
  • Country
  • XELB United States
  • QNRX United States
  • Employees
  • XELB N/A
  • QNRX 3
  • Industry
  • XELB Multi-Sector Companies
  • QNRX Medical/Dental Instruments
  • Sector
  • XELB Miscellaneous
  • QNRX Health Care
  • Exchange
  • XELB Nasdaq
  • QNRX Nasdaq
  • Market Cap
  • XELB 3.7M
  • QNRX 3.9M
  • IPO Year
  • XELB N/A
  • QNRX N/A
  • Fundamental
  • Price
  • XELB $1.10
  • QNRX $6.82
  • Analyst Decision
  • XELB
  • QNRX
  • Analyst Count
  • XELB 0
  • QNRX 0
  • Target Price
  • XELB N/A
  • QNRX N/A
  • AVG Volume (30 Days)
  • XELB 307.5K
  • QNRX 4.2K
  • Earning Date
  • XELB 08-13-2025
  • QNRX 08-07-2025
  • Dividend Yield
  • XELB N/A
  • QNRX N/A
  • EPS Growth
  • XELB N/A
  • QNRX N/A
  • EPS
  • XELB N/A
  • QNRX N/A
  • Revenue
  • XELB $7,407,000.00
  • QNRX N/A
  • Revenue This Year
  • XELB $23.96
  • QNRX N/A
  • Revenue Next Year
  • XELB $53.02
  • QNRX N/A
  • P/E Ratio
  • XELB N/A
  • QNRX N/A
  • Revenue Growth
  • XELB N/A
  • QNRX N/A
  • 52 Week Low
  • XELB $1.02
  • QNRX $5.01
  • 52 Week High
  • XELB $8.49
  • QNRX $54.95
  • Technical
  • Relative Strength Index (RSI)
  • XELB 20.32
  • QNRX 27.26
  • Support Level
  • XELB $1.50
  • QNRX $8.20
  • Resistance Level
  • XELB $1.69
  • QNRX $8.69
  • Average True Range (ATR)
  • XELB 0.13
  • QNRX 0.36
  • MACD
  • XELB -0.02
  • QNRX -0.22
  • Stochastic Oscillator
  • XELB 9.74
  • QNRX 6.47

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: